In the present study, L-4F treatment significantly decreases TNFα and PAI-1 expression in the ischemic brain which may partially contribute to L-4F treatment-induced vascular and WM protection in T2DM stroke mice. Here, TNF is linked to type 2 diabetes mellitus.